[1]
Maffezzoni, F.; Porcelli, T.; Delbarba, A.; Pezzaioli, L.; Cappelli, C.; Ferlin, A. Biomarkers of acromegaly and growth hormone action. Prot Peptide Lett., 2020, 27(12), 1231-1245.
[2]
Chiloiro, S.; Mirra, F.; Federico, D.; Giampietro, A.; Visconti, F.; Rossi, L.; Pontecorvi, A.; De Marinis, L.; Bianchi, A. The role of growth hormone receptor isoforms and their effects in bone metabolism and skeletal fragility. Prot Peptide Lett., 2020, 27(12), 1260-1267.
[3]
Pogliaghi, G. Triple-A Syndrome (TAS): An in-depth overview on genetic and phenotype heterogeneity. Prot Peptide Lett., 2020, 27(12), 1192-1203.
[4]
Maiorano, B.A.; Schinzari, G.; Chiloiro, S.; Visconti, F.; Milardi, D.; Bianchi, A. Proteomics of pancreatic neuroendocrine tumors: A systematic review. Prot Peptide Lett., 2020, 27(12), 1276-1287.
[5]
Cannarella, R.; Condorelli, R.A.; Calogero, A.E.; La Vignera, S. Novel insights on the role of the human sperm proteome. Prot Peptide Lett., 2020, 27(12), 1181-1185.
[6]
Grande, G.; Milardi, D.; Baroni, S.; Urbani, A.; Pontecorvi, A. Why Do we need new markers for male hypogonadism and how seminal proteomics might solve the problem? Prot Peptide Lett., 2020, 27(12), 1186-1191.
[7]
Facondo, P.; Delbarba, A.; Maffezzoni, F.; Cappelli, C.; Ferlin, A. INSL3: A marker of leydig cell function and testis-bone-skeletal muscle network. Prot Peptide Lett., 2020, 27(12), 1246-1252.
[8]
Porcelli, T.; Pezzaioli, L.; Delbarba, A.; Maffezzoni, F.; Cappelli, C.; Ferlin, A. Protein markers in osteoporosis. Prot Peptide Lett., 2020, 27(12), 1253-1259.